Yet Another Player in the Cardio-Oncology Conundrum?
作者： Ana Barac
DOI: 10.1016/J.JACC.2013.09.058
关键词:
摘要: An increasing number of oncology patients are seen by cardiologists every day, and a dilemma facing both the cardiologist oncologist is how to predict risk cardiac toxicity. Efficacious therapies targeting malignant cancers now recognized as potentially harmful for heart. Many
elsevier.com
onlinejacc.org 参考文章(9)
S Misawa, S Horiike, K Kashima, H Kaneko, T Iwai, M Nakao, S Yokota, T Fujimoto, Y Sonoda, Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. ,vol. 10, pp. 1911- 1918 ,(1996)
Gregory M. Cote, Douglas B. Sawyer, Bruce A. Chabner, ERBB2 Inhibition and Heart Failure The New England Journal of Medicine. ,vol. 367, pp. 2150- 2153 ,(2012) , 10.1056/NEJMCIBR1203156
Otmar Pfister, Vera Lorenz, Angelos Oikonomopoulos, Lifen Xu, Stéphanie P. Häuselmann, Christopher Mbah, Beat A. Kaufmann, Ronglih Liao, Aleksandra Wodnar-Filipowicz, Gabriela M. Kuster, FLT3 Activation Improves Post-Myocardial Infarction Remodeling Involving a Cytoprotective Effect on Cardiomyocytes Journal of the American College of Cardiology. ,vol. 63, pp. 1011- 1019 ,(2014) , 10.1016/J.JACC.2013.08.1647
Oghenerukevwe Odiete, Michael F. Hill, Douglas B. Sawyer, Neuregulin in Cardiovascular Development and Disease Circulation Research. ,vol. 111, pp. 1376- 1385 ,(2012) , 10.1161/CIRCRESAHA.112.267286
Donald Small, FLT3 Mutations: Biology and Treatment Hematology. ,vol. 2006, pp. 178- 184 ,(2006) , 10.1182/ASHEDUCATION-2006.1.178
Bonnie Ky, Pimprapa Vejpongsa, Edward T.H. Yeh, Thomas Force, Javid J. Moslehi, Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies Circulation Research. ,vol. 113, pp. 754- 764 ,(2013) , 10.1161/CIRCRESAHA.113.300218
Ming Hui Chen, Risto Kerkelä, Thomas Force, Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics Circulation. ,vol. 118, pp. 84- 95 ,(2008) , 10.1161/CIRCULATIONAHA.108.776831
Alexander Levitzki, Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance Annual Review of Pharmacology and Toxicology. ,vol. 53, pp. 161- 185 ,(2013) , 10.1146/ANNUREV-PHARMTOX-011112-140341
Hind Lal, Kyle L. Kolaja, Thomas Force, Cancer genetics and the cardiotoxicity of the therapeutics. Journal of the American College of Cardiology. ,vol. 61, pp. 267- 274 ,(2013) , 10.1016/J.JACC.2012.05.066